Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation
Key Points
This review provides practical guidance on the implementation and validation of DCE-MRI studies in models of cancer.
Discusses continuous image acquisition during contrast agent injection.
Explores relationships with other quantitative imaging techniques.
Focuses on both preclinical and relevant clinical investigations.
Highlights the noninvasive nature of DCE-MRI for evaluating tumor vascularity.
Describes the importance of understanding data acquisition and analysis subtleties.
Abstract
Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) consists of the continuous acquisition of images before, during, and after the injection of a contrast agent. DCE-MRI allows for noninvasive evaluation of tumor parameters related to vascular perfusion and permeability and tissue volume fractions, and is frequently employed in both preclinical and clinical investigations. However, the experimental and analytical subtleties of the technique are not frequently discussed in the literature, nor are its relationships to other commonly used quantitative imaging techniques. This review aims to provide practical information on the development, implementation, and validation of a DCE-MRI study in the context of a preclinical study (though we do frequently refer to clinical studies that are related to these topics).
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Practical Dynamic Contrast Enhanced MRI in Small Animal Models of Cancer: Data Acquisition, Data Analysis, and Interpretation | Synapse
What's going on 進行結腸直腸がんに対してのオキサリプラチンを用いた一次治療におけるベバシズマブの上乗せ効果[Saltz LB, Clarke S, Diaz-Rubio E, Scheithauer W, Figer A, Wong R, Koski S, Lichinitser M, Yang TS, Rivera F, Couture F, Sirzen F, Cassidy J 'Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase 3 study']2009 · 61 citations